Norbert-Claude Gorin, MD, PhD, Saint-Antoine Hospital and Sorbonne University, Paris, France, gives an overview of the main changes that have occurred in the field of hematopoietic stem cell transplantation (HSCT) since its introduction, commenting on stem cell source, conditioning regimens, donor registries, and haploidentical transplantation. This interview took place at the 49th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
